about
Targeting Hepatocellular Carcinoma: What did we Discover so Far?Recent advances in hepatocellular carcinoma therapy.The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patientsmiR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma.Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice.Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma.Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis.Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation.Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma.CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways.Resolvin D1 inhibits the proliferation of lipopolysaccharide-treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway
P2860
Q28077283-1423FB95-3BFD-4175-B239-C994FB99258EQ30236010-5D9642CB-78EC-4F5E-AAD2-D7E3510BD28FQ33885293-43E2C864-D6EB-4A20-886A-9F7CADBEF1E8Q36166685-345519C9-3C6E-4753-98FA-40060C49FE0DQ37426851-66AC9E15-E00C-49E7-8E96-52A06071B61BQ37457607-A52F810C-6392-43F0-9156-76F7DD251933Q37654423-56352F58-8095-45FE-9224-8D135381809FQ38772074-B86311DD-B464-477F-9E4F-1B7874BEBBA9Q38866308-CC27A04F-C43D-4062-BAD5-A349B97B41F0Q38923977-10942911-99ED-408E-8D4F-8C9A3F92359FQ39001915-44942A4E-541C-4A08-A15F-D6C61B68AEE3Q39328422-0C42870B-4F8C-48BD-B396-15A1808000E9Q40043181-02C43130-41DD-4461-B119-19BDFA33257AQ41412971-875A1969-C111-42EB-A6EC-51FE575F1E44Q41592701-B7F6115F-8AA8-402B-92E6-45ED383C86C0Q41651606-C591038F-9D6E-4146-98D2-406AF84FD51EQ46519493-0D55D87A-234C-44AF-8BC3-AD8E71A368ABQ46890816-2BFCE64A-FE93-4CB3-A92A-FDB6DCAF9B73Q47160108-EB5E859B-6E53-4958-BBA6-59C711A76969Q47574391-696AF52F-FE23-4230-B598-C094177249E7Q48597130-9EFA4277-10D8-4B6F-A0DF-363D73908EA3Q49402953-73076942-E02A-4112-918F-3B397345E661Q49507209-2A6CB3C2-929F-4544-BA5F-2D049C95A25EQ52726205-9B9FC12F-2525-438F-B655-FEF3EF308764Q58710795-AEF01563-A68A-4751-A45B-E8E9706479FA
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New advances in hepatocellular carcinoma
@ast
New advances in hepatocellular carcinoma
@en
New advances in hepatocellular carcinoma
@nl
type
label
New advances in hepatocellular carcinoma
@ast
New advances in hepatocellular carcinoma
@en
New advances in hepatocellular carcinoma
@nl
prefLabel
New advances in hepatocellular carcinoma
@ast
New advances in hepatocellular carcinoma
@en
New advances in hepatocellular carcinoma
@nl
P2093
P2860
P3181
P356
P1476
New advances in hepatocellular carcinoma
@en
P2093
Iván Herrera
Javier Irurzun
Sonia Pascual
P2860
P304
P3181
P356
10.4254/WJH.V8.I9.421
P407
P577
2016-03-28T00:00:00Z